2025 Ranking of the World’s Top 13 IVD Corporations

By Mark Terry | From the Volume XXXII, No. 13 – September 15, 2025 Issue

BASED ON PUBLICLY-REPORTED 2024 DIAGNOSTICS-RELATED REVENUE, four in vitro diagnostics (IVD) companies continue to dominate the global market, as they have for the last two years: Thermo Fisher Scientific, Roche, Danaher, and Abbott Laboratories. The top 13 companies …

Read More

---

Despite Trade Tariffs, IVD Firms Report Upbeat Earnings

By Mark Terry | From the Volume XXXII, No. 12 – August 25, 2025 Issue

LEADING IN VITRO DIAGNOSTICS (IVD) COMPANIES RECENTLY REPORTED POSITIVE QUARTERLY FINANCIALS despite swirling concerns about trade tariffs and cuts to US federal research grants. It’s not yet clear what the long-term effect of tariffs’ will be on IVD manu…

Read More

---

At ADLM 2025, Spotlight Shines on Relationships

By Scott Wallask | From the Volume XXXII, No. 11 – August 4, 2025 Issue

CEO SUMMARY: At the ADLM conference, a new industry survey about the dynamic relationship between medical laboratories, physicians, and patients presented a strong argument for labs taking the lead in communicating and being more accessible to their colleagues. A troubleso…

Read More

---

Fast, $17.5B Deal Lands Waters Corp. in IVD Market

By Janette Wider | From the Volume XXXII, No. 11 – August 4, 2025 Issue

WHEN BECTON DICKINSON  (BD) ANNOUNCED ITS INTENT to spin off its in vitro diagnostics (IVD) and life sciences units in February, few observers expected a deal to close just five months later. But now that such an agreement has occurred as of July 14, the buy…

Read More

---

Global IVD Companies Issue Fourth Quarter 2024 Earnings

By Robert Michel | From the Volume XXXII, No. 5 – March 31, 2025 Issue

OVERALL, IN VITRO DIAGNOSTICS (IVD) COMPANIES REPORTED A MIXED BAG of financial results for the quarter ending Dec. 31, 2024, with Becton, Dickinson and Company, Abbott Laboratories, and Siemens Healthineers showing the most momentum based on r…

Read More

---

March 10, 2025, Intelligence: Late-Breaking Lab News

By Robert Michel | From the Volume XXXII, No. 4 – March 10, 2025 Issue

Genetic testing is coming to a cruise ship! The New York Post reported that the MV Narrative will be launched this year by Storylines. CruiseCritic describes this vessel as “a residential ship that will create a floating ‘neighborhood’ for a community of up to 1,000 people, including f…

Read More

---

Global IVD Companies Issue Third Quarter 2024 Earnings

By Robert Michel | From the Volume XXXI, No. 16 – November 25, 2024 Issue

HERE IS A SUMMARY OF THE THIRD QUARTER FINANCIAL PERFORMANCE of t…

Read More

---

Global IVD Companies Report Second Quarter 2024 Earnings

By Robert Michel | From the Volume XXXI, No. 13 – September 23, 2024 Issue

IN THE SECOND QUARTER OF 2024, in vitro diagnostics (IVD) companies reported solid revenues as well as new tests, analyzers, and automation. Most of the IVD companies boosted diagnostic sales in low single digit amounts. During the earnings calls, financial analysts asked company leade…

Read More

---

August 12, 2024, Intelligence: Late-Breaking Lab News

By Robert Michel | From the Volume XXXI, No. 11 – August 12, 2024 Issue

In recent years, many of the national retail pharmacy chain operators announced big plans to open primary care clinics. Now, after substantial investments of billions of dollars, those same retail pharmacy chains are unwinding these business lines. This spring, Walmart announced it w…

Read More

---

2023 Ranking of the World’s Top 13 IVD Corporations

By Robert Michel | From the Volume XXXI, No. 10 – July 22, 2024 Issue

BASED ON 2023 DIAGNOSTICS-RELATED REVENUE, four in vitro diagnostics (IVD) manufacturers continued to lead the global IVD market just as they did in 2022. They are: Thermo Fisher Scientific, Inc., Roche Holdings, Abbott Laboratories, and Danaher Corporation. Th…

Read More

---